Di Mitri D, Conforti F, Mantovani A. Macrophages and bone metastasis. J Exp Med. 2023 Apr 3;220(4):e20222188. doi: 10.1084/jem.20222188. Epub 2023 Feb 24. PMID: 36828392
Marelli G, Morina N, Portale F, Pandini M, Iovino M, Di Conza G, Ho PC, Di Mitri D. Lipid-loaded macrophages as new therapeutic target in cancer. J Immunother Cancer. 2022 Jul;10(7):e004584. doi: 10.1136/jitc-2022-004584. PMID: 35798535
Alvisi G, Termanini A, Di Mitri D, Lugli E, Lleo A. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. J Hepatol. 2022 Jun 20:S0168-8278(22)00370-1. doi: 10.1016/j.jhep.2022.05.043
Masetti M., Carriero R, Di Mitri D. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med 2021.
Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020 Jul 21. doi: 10.1038/s41568-020-0281-y.
Di Mitri D, De Bono J, Alimonti A. Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer. Cell Reports. 2019 Aug 20;28(8):2156-2168.e5. doi: 10.1016/j.celrep.2019.07.068.
Arianna Calcinotto, Clarissa Spataro, Diletta Di Mitri, De Bono & Andrea Alimonti. IL23 secreted by myeloid-derived suppressor cells confers castration resistance in prostate cancer. Nature. 2018 Jul;559(7714):363-369. doi: 10.1038/s41586-018-0266-0. Epub 2018 Jun 27. PMID: 29950727
Chen J, Guccini I, Di Mitri D, …, Bono J, Carracedo A, Alimonti A. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet. 2018 Feb;50(2):219-228. doi: 10.1038/s41588-017-0026-3. Epub 2018 Jan 15.
Di Mitri D, Sambucci M, Borsellino G, Battistini L. The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis. Immunology. 2015 Oct;146(2):251-63. doi: 10.1111/imm.12497. Epub 2015 Jul 6. PubMed PMID: 26095162; PubMed Central PMCID: PMC4582966.
Di Mitri D, Alimonti A. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature. 2014 Nov 6;515(7525):134-7. doi: 10.1038/nature13638. Epub 2014 Aug 24. PubMed PMID: 25156255
Di Mitri D, Azevedo RI, Battistini L, Akbar AN. Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol. 2011 Sep 1;187(5):2093-100. doi: 10.4049/jimmunol.1100978. Epub 2011 Jul 25. PubMed PMID: 21788446.